XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 9,825 $ 6,230
General and administrative 1,028 915
Total operating expenses 10,853 7,145
Loss from operations (10,853) (7,145)
Interest income 2,658 2,779
Other (expense) income (200) 130
Foreign exchange (loss) gain (1,582) 383
Total other income 876 3,292
Loss before income taxes (9,977) (3,853)
Income tax expense (25) (37)
Net loss $ (10,002) $ (3,816)
Net loss per share—basic and diluted (in dollars per share) $ (0.33) $ (0.13)
Shares used to compute basic and diluted net loss per share (in shares) 30,443,973 30,439,275